SCHEMBL5659626

SCHEMBL5659626

O=C(NCCCc1cccc(C(F)(F)F)c1)Nc1cccc2cnccc12

nearest known ligand 0.89

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 20/20 0.89

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4029208 0.94 TRPV1 (1.00) TRPV1
SCHEMBL5658588 0.92 TRPV1 (0.75) TRPV1
SCHEMBL5658624 0.90 TRPV1 (0.88) TRPV1
SCHEMBL4027175 0.88 TRPV1 (1.00) TRPV1
SCHEMBL6581740 0.86 TRPV1 (0.66) TRPV1
SCHEMBL4026884 0.85 TRPV1 (0.87) TRPV1
SCHEMBL5391703 0.84 TRPV1 (1.00) TRPV1
SCHEMBL5659714 0.83 TRPV1 (0.68) TRPV1
SCHEMBL5659488 0.83 TRPV1 (0.86) TRPV1
SCHEMBL5664749 0.82 TRPV1 (0.66) TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7285563-B2 Heteroaromatic urea derivatives as VR-1 receptor modulators for treating pain MERCK SHARP & DOHME LTD. (GB) 2007-10-23 US disclosed
US-20050107388-A1 Heteroaromatic urea derivatives as vr-1receptor modulators for treating pain MERCK SHARP & DOHME LTD. (GB) 2005-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107388-A1 Heteroaromatic urea derivatives as vr-1receptor modulators for treating pain ARRB1, OPRL1, CNR1 TRPV1 37/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.